Loading...

Medical Facilities Corporation

MFCSFPNK
Healthcare
Medical - Care Facilities
$10.52
$-0.08(-0.75%)

Medical Facilities Corporation (MFCSF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Medical Facilities Corporation (MFCSF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-25.60%
25.60%
Operating Income Growth
-8.15%
8.15%
Net Income Growth
297.18%
297.18%
Operating Cash Flow Growth
14.54%
14.54%
Operating Margin
18.41%
18.41%
Gross Margin
65.05%
65.05%
Net Profit Margin
28.90%
28.90%
ROE
90.38%
90.38%
ROIC
24.21%
24.21%

Medical Facilities Corporation (MFCSF) Income Statement & Financial Overview

Review Medical Facilities Corporation MFCSF income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$81.71M$12.52M$103.57M$107.17M
Cost of Revenue$27.47M$10.44M$32.39M$34.00M
Gross Profit$54.24M$2.09M$71.19M$73.18M
Gross Profit Ratio$0.66$0.17$0.69$0.68
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$36.97M-$3.08M$52.73M$50.31M
Operating Expenses$41.24M$1.36M$45.65M$55.20M
Total Costs & Expenses$68.71M$11.80M$78.04M$89.20M
Interest Income$1.04M$1.42M$144000.00$130000.00
Interest Expense$5.20M-$16.09M$8.04M$11.56M
Depreciation & Amortization$4.27M$4.72M$4.88M$4.89M
EBITDA$18.12M$6.83M$30.48M$22.92M
EBITDA Ratio$0.22$0.55$0.29$0.21
Operating Income$13.001M$725000.00$25.54M$17.98M
Operating Income Ratio$0.16$0.06$0.25$0.17
Other Income/Expenses (Net)-$4.34M$17.52M-$7.97M-$11.51M
Income Before Tax$8.66M$18.25M$17.56M$6.47M
Income Before Tax Ratio$0.11$1.46$0.17$0.06
Income Tax Expense-$321000.00-$6.03M$141000.00-$178000.00
Net Income$3.73M$64.84M$7.25M-$370000.00
Net Income Ratio$0.05$5.18$0.07-$0.003
EPS$0.12$3.51$0.39-$0.02
Diluted EPS$0.12$2.67$0.30-$0.02
Weighted Avg Shares Outstanding$22.18M$18.50M$18.50M$18.50M
Weighted Avg Shares Outstanding (Diluted)$22.18M$24.30M$24.30M$24.30M

Over the past four quarters, Medical Facilities Corporation demonstrated steady revenue growth, increasing from $107.17M in Q2 2024 to $81.71M in Q1 2025. Operating income reached $13.001M in Q1 2025, maintaining a consistent 16% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $18.12M, reflecting operational efficiency. Net income dropped to $3.73M, with EPS at $0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;